USE OF HORMONAL CONTRACEPTIVES IN A REHABILITATION PROGRAM AFTER PRIOR EXACERBATION OF CHRONIC SALPINGOOPHORITIS

Objective. To assess a role of combination oral contraceptives with different progestagen components in a package of rehabilitative measures after prior exacerbation of chronic salpingoophoritis. Subjects and methods. One hundred and eight women treated at hospital for exacerbation of chronic salpingoophoritis were examined and divided into 3 groups: 1) 42 patients who were given a drospirenone-containing combination oral contraceptive (COC); 2) 35 patients who took desogestrel-containing COC; 3) 31 patients who received no hormonal contraceptives. Results. Comparison of the pattern of genital diseases in women using drospirenone- and desogestrel-containing COC revealed no statistically significant differences: both agents ensurd a good control of the menstrual cycle, a reduction in the degree of dysmenorrheal symptoms, the absence of functional ovarian cysts and endometrial hyperplasia, a decrease in the rate of exacerbations of chronic salpingoophoritis. However, the women receiving drospirenone-containing COC showed a better tolerability profile, a lower frequency of side effects, including no action on weight and blood pressure, as well as no peripheral edemas. Conclusion. The high efficacy of drospirenone with the lower frequency of adverse reactions allows this agent to be recommended in the package of rehabilitative measures in patients with chronic salpingoophoritis.

chronic salpingoophoritis, combination oral contraceptives, drospirenone